Theodore Deweese
Expertise in
2
conditions

Dr. Theodore Deweese

Radiation Oncology
Johns Hopkins Medicine
Sidney Kimmel Comprehensive Cancer Center
401 North Broadway Street, Weinberg BLDG, Floor-L1 (Lobby Level), Weinberg BLDG, Floor-L1 (Lobby Level), 
Baltimore, MD 

Expertise in
2
conditions
Johns Hopkins Medicine
Sidney Kimmel Comprehensive Cancer Center
401 North Broadway Street, Weinberg BLDG, Floor-L1 (Lobby Level), Weinberg BLDG, Floor-L1 (Lobby Level), 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Theodore DeWeese is The Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D. Dean of the Medical Faculty and CEO, Johns Hopkins Medicine. Dr. DeWeese is professor of oncology and urology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include prostate cancer, radiation oncology and urological oncology. He and his colleagues focus their research on developing new ways to enhance radiation-induced killing of prostate cancer cells. This includes development of novel, prostate cancer-targeted RNA molecules as well as new ways to modulate androgen receptor signaling. He and his colleagues also developed the first adenoviral gene therapy trial for prostate cancer, using a common cold virus to target cancer cells while leaving normal cells unharmed. Dr. DeWeese earned his M.D. from the University of Colorado Health Sciences Center. He completed his residency at The Johns Hopkins Hospital, serving as chief resident, and performed a laboratory research fellowship at the Johns Hopkins Oncology Center and the James Buchanan Brady Urological Institute. Dr. DeWeese's research interests include prostate cancer, DNA damage, and radiation sensitization. Dr. DeWeese has served on numerous committees and boards including as President and Chair of the Board for the American Society for Radiation Oncology. He also serves on committees for the American Association for Cancer Research and was appointed by the National Academy of Sciences as a scientific counselor for the Radiation Effects Research Foundation in Hiroshima, Japan. He has received numerous awards and honors, including several teaching awards from Johns Hopkins. Make A Gift.

Dr. Deweese is highly rated in 2 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bone Tumor, Prostatectomy, and Orchiectomy.

His clinical research consists of co-authoring 144 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Johns Hopkins University School of Medicine, Radiation Oncology, 1994
Specialties
Radiation Oncology
Licenses
Radiology in MD
Board Certifications
American Board Of Radiology
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

Sidney Kimmel Comprehensive Cancer Center
401 North Broadway Street, Weinberg BLDG, Floor-L1 (Lobby Level), Weinberg BLDG, Floor-L1 (Lobby Level), Baltimore, MD 21287
Call: 410-502-8000
Other Locations
Sidney Kimmel Comprehensive Cancer Center
401 North Broadway Street, Weinberg Building, Floor-L2, Baltimore, MD 21287
Call: 410-502-8000

Additional Areas of Focus

Dr. Deweese has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Prostate Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
Enrollment Status: Completed
Publish Date: February 11, 2026
Intervention Type: Drug, Radiation
Study Drug: Androgen deprivation therapy 
Study Phase: Phase 1/Phase 2
Non-invasive Detection of Cancer DNA in Blood and Urine
Non-invasive Detection of Cancer DNA in Blood and Urine
Enrollment Status: Completed
Publish Date: December 23, 2025
Intervention Type: Procedure
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
A Phase II Randomized Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS)
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Drug, Radiation
Study Drug: Radium-223
Study Phase: Phase 2
Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer
Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other
Study Phase: Not Applicable
Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy
Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men With High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy
Enrollment Status: Completed
Publish Date: October 28, 2025
Intervention Type: Drug, Radiation
Study Drug: Enzalutamide
Study Phase: Phase 2
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Randomized Trial Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Other, Drug
Study Drug: Flutamide
Study Phase: Early Phase 1
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Biological
Study Drugs: Aglatimagene besadenovec, Valacyclovir
Study Phase: Phase 3
Evaluation of PSMA-based PET as an Imaging Biomarker of Androgen Receptor Signaling in High-Risk Localized and Locally Advanced Prostate Cancer
Evaluation of PSMA-based PET as an Imaging Biomarker of Androgen Receptor Signaling in High-Risk Localized and Locally Advanced Prostate Cancer
Enrollment Status: Completed
Publish Date: March 19, 2025
Intervention Type: Drug
Study Drug: DCFPyL
Study Phase: Early Phase 1
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2
View 8 Less Clinical Trials

144 Total Publications

Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer.
Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2025
View All 144 Publications
Similar Doctors
Lawrence R. Kleinberg
Expertise in
28
conditions
Dr. Lawrence R. Kleinberg
Radiation Oncology
Expertise in
28
conditions
Dr. Lawrence R. Kleinberg
Radiation Oncology

Sidney Kimmel Comprehensive Cancer Center

401 North Broadway Street, Weinberg BLDG, Floor-L1 (Lobby Level), Weinberg BLDG, Floor-L1 (Lobby Level), 
Baltimore, MD 
 (1.2 miles away)
410-502-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Kleinberg specializes in the radiation treatments, including stereotactic radiosurgery, of brain and spinal tumors. Areas of research include both tumors arising in the central nervous system and tumors metastasizing from other locations. He also specializes in the treatment of esophageal tumors and has led national clinical trials in both therapy of brain tumors as well as esophageal cancer. Dr. Kleinberg has been recently named in the US News and World Report list of top 1% of doctors in his specialty. He is the co-chair of the Eastern Cooperative Oncology Group Brain Tumor Working Group, Vice-Chair of the NCI Cooperative Group Steering Committee for Esophageal and Gastric Tumors, and is a member of the NCI Cooperative Group Steering Committee for Gastrointestinal Tumors. He is also on the American College of Radiation Oncology Neurologic Cancer Practice Accreditation Team. Make A Gift. Dr. Kleinberg is highly rated in 28 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Glioma, and Hepato-Pancreato-Biliary Surgery.

Kristin J. Redmond
Expertise in
33
conditions
Dr. Kristin J. Redmond
Radiation Oncology
Expertise in
33
conditions
Dr. Kristin J. Redmond
Radiation Oncology

Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD 
 (1.2 miles away)
410-502-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is highly rated in 33 conditions, according to our data. Her top areas of expertise are Brain Tumor, Chordoma, Astrocytoma, and Metastatic Brain Tumor.

Russell Hales
Expertise in
18
conditions
Dr. Russell Hales
Radiation Oncology
Expertise in
18
conditions
Dr. Russell Hales
Radiation Oncology

Johns Hopkins Bayview Medical Center

4940 Eastern Avenue, 
Baltimore, MD 
 (2.5 miles away)
410-550-0100
Languages Spoken:
English
See accepted insurances

Russell Hales, M.D., is an assistant professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also is director of the thoracic multidisciplinary clinic. His research focuses on reconstructing health delivery models to enhance value and improve clinical outcomes. He also studies the effect of immunotherapy and RT in thoracic tumors. Dr. Hales was awarded an R21 grant to study the use of dynamic MRI in predicting tumor motion in patient with lung cancer. Taken together, his research focuses on optimizing patient outcomes using resources from physics, engineering, biology and health delivery systems. Dr. Hales’ efforts extend beyond radiation oncology and clinical management. He has helped to lead in the thoracic oncology program, which includes 20 faculty members and nearly 50 staff, to help chart a vision for this program’s future. In the last four years, the program has gradually transitioned from The Johns Hopkins Hospital campus to Johns Hopkins Bayview Medical Center. Dr. Hales was tasked to head the building and design committee that worked with architects to create a structure conducive to 21st century oncology care. His work extends beyond the bricks and mortar of the new cancer center today to team development within the thoracic oncology program. Simply put, the thoracic oncology move was designed to conceptualize the transition of care from department-based to disease-based medicine. As such, Dr. Hales has worked to integrate the efforts of specialists in medical oncology, thoracic surgery, interventional pulmonology, pathology and radiology. These experts share a clinical space focused on thoracic malignancies and bring a patient-centered model of care to their group. Dr. Hales graduated from Brigham Young University Summa Cum Laude and Valedictorian in 2001. He attended Johns Hopkins Medicine and graduated with an M.D. in 2005. He trained on the Osler Medical Service and attended residency at Johns Hopkins. He joined the faculty at Hopkins in 2010. Dr. Hales focus in program building, research and clinical endeavors is robust, but he understands the key role of academia in training future leaders in medicine. He has been awarded Teacher of the Year in the department of radiation oncology at Hopkins for three of the last six years. He is a well-respected lecturer and travels nationally to speak at conferences and educational workshops about novel therapies in lung and esophagus cancer. Make A Gift. Dr. Hales is highly rated in 18 conditions, according to our data. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Thymic Epithelial Tumor, Non-Small Cell Lung Cancer (NSCLC), and Endoscopy.

VIEW MORE Radiation Oncologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Deweese's expertise for a condition
ConditionClose
    • Distinguished
    • Prostate Cancer
      Dr. Deweese is
      Distinguished
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Advanced
    • Prostatectomy
      Dr. Deweese is
      Advanced
      . Learn about Prostatectomy.
      See more Prostatectomy experts
    • Experienced
    • Bone Tumor
      Dr. Deweese is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Familial Prostate Cancer
      Dr. Deweese is
      Experienced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Orchiectomy
      Dr. Deweese is
      Experienced
      . Learn about Orchiectomy.
      See more Orchiectomy experts
    • Pancreatic Cancer
      Dr. Deweese is
      Experienced
      . Learn about Pancreatic Cancer.
      See more Pancreatic Cancer experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Radiation Oncologists Baltimore, MD
    3. Dr. Theodore Deweese
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

      Patient Details

      This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.